Qingfang Xu

Dr. Qingfang Xu

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2022 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
JFJiaqi Fang
Jiaqi Fang
MOMengting Ouyang
Mengting Ouyang
YQYingying Qu
Yingying Qu
MWMengyao Wang
Mengyao Wang
XHXianyin Huang
Xianyin Huang
QXQingfang Xu
Qingfang Xu

1 June 2018 in Journal of Dermatological Science
Verified
Journal Article
Closed access
XXXinya Xu
Xinya Xu
YZYue Zheng
Yue Zheng
YHYunfen Huang
Yunfen Huang
JCJian Chen
Jian Chen
ZGZijian Gong
Zijian Gong
QXQingfang Xu
Qingfang Xu

1 October 2019 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
YHYunfen Huang
Yunfen Huang
YLYuying Li
Yuying Li
YQYingying Qu
Yingying Qu
YZYue Zheng
Yue Zheng
MOMengting Ouyang
Mengting Ouyang
QXQingfang Xu
Qingfang Xu

6 October 2020 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
PDF file
YLYao Lin
Yao Lin
MLMengbi Lin
Mengbi Lin
YLYufang Liu
Yufang Liu
JZJie Zhang
Jie Zhang
WLWei Lai
Wei Lai
YZYue Zheng
Yue Zheng

26 March 2014 in The Journal of Headache and Pain
Verified
Journal Article
Open access
PDF file
MCMing-Chun Chen
Ming-Chun Chen
QXQingfang Xu
Qingfang Xu
DLDi-Qing Luo
Di-Qing Luo
XLXiang Li
Xiang Li
DHDing-Yang He
Ding-Yang He
Erythermalgia is a rare cutaneous disorder characterized by attacking of erythema, pain and increased temperature, which primarily involves the extremities and may infrequently extend to the neck, face, ears and even the scrotum. We reported an 18-year-old woman who presented with 3 years history of sole involvement of attacking erythema, pain and warmth over her face and ears without any other associations. The frequency and severity of the flares progressed gradually during the course. Cutaneous examination revealed erythema, increased temperature and tenderness on the face and ears during the flare. The symptoms could be relieved rapidly by cooling. Dermatoscope showed that vessels inside the erythema were more dilated during the episode than after application of ice. The lesion is considered a rare variant of erythermalgia with sole involvement of face and ears. The symptoms had mild response to oral antihistamines, topical steroids and tacrolimus, but had excellent response to the combinative therapy of aspirin and paroxetins.

5 December 2016 in Chinese Medical Journal
Verified
Journal Article
Open access
PDF file
QXQingfang Xu
Qingfang Xu
YZYue Zheng
Yue Zheng
JCJian CHEN
Jian CHEN
XXXinya Xu
Xinya Xu
ZGZi-Jian Gong
Zi-Jian Gong
WLWei Lai
Wei Lai
Background: Cathepsin L (CatL) is a cysteine protease with strong matrix degradation activity that contributes to photoaging. Mannose phosphate-independent sorting pathways mediate ultraviolet A (UVA)-induced alternate trafficking of CatL. Little is known about signaling pathways involved in the regulation of UVA-induced CatL expression and activity. This study aims to investigate whether a single UVA irradiation affects CatL expression and activity and whether mitogen-activated protein kinase (MAPK)/activator protein-1 (AP-1) pathway is involved in the regulation of UVA-induced CatL expression and activity in human dermal fibroblasts (HDFs).Methods: Primary HDFs were exposed to UVA. Cell proliferation was determined by a cell counting kit. UVA-induced CatL production and activity were studied with quantitative real-time reverse transcription polymerase chain reaction (RT-PCR), Western blotting, and fluorimetric assay in cell lysates collected on three consecutive days after irradiation. Time courses of UVA-activated JNK and p38MAPK signaling were examined by Western blotting. Effects of MAPK inhibitors and knockdown of Jun and Fos on UVA-induced CatL expression and activity were investigated by RT-PCR, Western blotting, and fluorimetric assay. Data were analyzed by one-way analysis of variance.Results: UVA significantly increased CatL gene expression, protein abundance, and enzymatic activity for three consecutive days after irradiation (F = 83.11, 56.14, and 71.19, respectively; all P < 0.05). Further investigation demonstrated phosphorylation of JNK and p38MAPK activated by UVA. Importantly, inactivation of JNK pathway significantly decreased UVA-induced CatL expression and activity, which were not affected by p38MAPK inhibition. Moreover, knockdown of Jun and Fos significantly attenuated basal and UVA-induced CatL expression and activity.Conclusions: UVA enhances CatL production and activity in HDFs, probably by activating JNK and downstreaming AP-1. These findings provide a new possible molecular approach for antiphotoaging therapy.